Opocher, Giuseppe

Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors

Arlt, W., Biehl, M., Taylor, A. E., Hahner, S., Libé, R., Hughes, B. A., Schneider, P., Smith, D. J., Stiekema, H., Krone, N., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsMetabolomics and Mass Spectrometry Studies

Cited by 458

Germline mutations in TMEM127 confer susceptibility to pheochromocytoma

Qin, Y., Yao, L., King, E. E., Buddavarapu, K., Lenci, R. E., Chocron, E. S., Lechleiter, J. D., Sass, M., Aronin, N., Schiavi, F., et al. (2010) · Nature Genetics

Adrenal and Paraganglionic TumorsNeurofibromatosis and Schwannoma Cases

Cited by 379

Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study

Toniato, A., Merante-Boschin, I., Opocher, G., Pelizzo, M. R., Schiavi, F., & Ballotta, E. (2009) · Annals of Surgery

Adrenal and Paraganglionic TumorsPituitary Gland Disorders and Treatments

Cited by 245

Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement

Chortis, V., Taylor, A. E., Schneider, P., Tomlinson, J. W., Hughes, B. A., O'Neil, D. M., Libé, R., Allolio, B., Bertagna, X., Bertherat, J., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 154

Insulin Resistance in Cushing’s Syndrome*

NOSADINI, R., DEL PRATO, S., TIENGO, A., VALERIO, A., MUGGEO, M., OPOCHER, G., MANTERO, F., DUNER, E., MARESCOTTI, C., MOLLO, F., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism

Pancreatic function and diabetesGrowth Hormone and Insulin-like Growth Factors

Cited by 146

Krebs Cycle Metabolite Profiling for Identification and Stratification of Pheochromocytomas/Paragangliomas due to Succinate Dehydrogenase Deficiency

Richter, S., Peitzsch, M., Rapizzi, E., Lenders, J. W., Qin, N., de Cubas, A. A., Schiavi, F., Rao, J. U., Beuschlein, F., Quinkler, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsMetabolism and Genetic Disorders

Cited by 135

Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma

Terzolo, M., Bovio, S., Pia, A., Conton, P. A., Reimondo, G., Dall’Asta, C., Bemporad, D., Angeli, A., Opocher, G., Mannelli, M., et al. (2005) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsHormonal Regulation and Hypertension

Cited by 89

Renin-Angiotensin-Aldosterone System: A Long-Term Follow-Up Study in 17α-Hydroxylase Deficiency Syndrome (17OHDS)

Scaroni, C., Opocher, G., & Mantero, F. (1986) · Clinical and Experimental Hypertension. Part A: Theory and Practice

Hormonal Regulation and HypertensionRenin-Angiotensin System Studies

Cited by 13